Abstract
The guidelines for diagnosing and managing perinatal SARS-CoV-2 infection for the Indian context were last updated in May 2020. Newer evidence, the evolution of the pandemic, and its significant impact on mother-infant dyads led us to review and revise the guideline. This article summarizes the salient changes in the perinatal-neonatal management of COVID-19.
Keywords: Newborn, Pregnancy, SARS-CoV-2
References
- 1.Cherian S, Potdar V, Jadhav S, et al. SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. Microorganisms. 2021;9:1542. doi: 10.3390/microorganisms9071542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Chawla D, Chirla D, Dalwai S, et al. Perinatal-Neonatal Management of COVID-19 Infection — Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP) Indian Pediatr. 2020;57:536–48. doi: 10.1007/s13312-020-1852-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Indian Council of Medical Research (ICMR). Advisory for COVID-19 testing during the second wave of the pandemic. Accessed My 25, 2021. Available from: https://www.icmr.gov.in/pdf/covid/strategy/Advisory_COVID_Testing_in_Second_Wave_04052021.pdf
- 4.Perinatal-Neonatal Management of COVID-19- Clinical practice guidelines (Version 3.0). Accessed Aug 20, 2021. Available from: https://www.nnfi.org/assests/upload/usefull-links-pdf/NNF_FOGSI%20IAP_Perinatal-Neonatal_Covid_CPG_June_16–2021.pdf
- 5.Villar J, Ariff S, Gunier RB, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175:817–26. doi: 10.1001/jamapediatrics.2021.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mullins E, Hudak ML, Banerjee J, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 2021;57:573–81. doi: 10.1002/uog.23619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Allotey J, Stallings E, Bonet M, PregCOV-19 living systematic review consortium et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.RECOVERY Collaborative Group. Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Magala S A, Sserwanja Q, Olal E, et al. Corticosteroids use in pregnant women with COVID-19: Recommendations from available evidence. J Multidiscip Healthc. 2021;14:659–63. doi: 10.2147/JMDH.S301255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.World Health Organization. Corticosteroids for COVID-19. Accessed May 29, 2021. Available from: https://apps.who.int/iris/rest/bitstreams/1299344/retrieve
- 11.More K, Chawla D, Murki S, et al. National Neonatology Forum (NNF) COVID-19 Registry Group. Outcomes of neonates born to mothers with coronavirus disease 2019 (COVID-19) — National Neonatology Forum (NNF) India COVID-19 Registry. Indian Pediatr. 2021;58:525–31. doi: 10.1007/s13312-021-2234-2. [DOI] [PMC free article] [PubMed] [Google Scholar]